Inhibition of CDK9 attenuates atherosclerosis by inhibiting inflammation and phenotypic switching of vascular smooth muscle cells

CONCLUSION: These results indicate that inhibition of CDK9 may be a novel therapeutic target for the prevention of atherosclerosis.PMID:34102609 | DOI:10.18632/aging.202998

Source: Aging - June 8, 2021 Category: Biomedical Science Authors: Shushi Huang Wu Luo Gaojun Wu Qirui Shen Zaishou Zhuang Daona Yang Jinfu Qian Xiang Hu Yan Cai Nipon Chattipakorn Weijian Huang Guang Liang Source Type: research